Patrick Geiser

Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA.

Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland.

PHT International, Inc. is a full-service chemical manufacturer that has been serving the industrial chemicals community for over 25 years. The private company is based in Charlotte, NC, and was founded in 1993 by Li Hong Yu. The company offers customized chemical manufacturing solutions for companies in various industries, including pharmaceuticals and agrochemicals. PHT provides end-to-end production solutions, including procurement, logistics, and regulatory compliance. The company specializes in custom manufacturing, research and development, and quality assurance. PHT's green chemistry processes streamline production and reduce organic waste, lessening the environmental footprint.

Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA.

Nelson Bach Usa Ltd. is based in North Andover. Nelson Bach USA Ltd. is a leading manufacturer of natural healthcare products with an impressive portfolio. The company is the home of Nelsons, which has been trusted by generations worldwide for over 85 years to provide families with natural healthcare products. Nelsons has been in operation since 1860.

Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd.